Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Allergy|May 1, 1986
Oral immunotherapy of children with rhinoconjunctivitis due to birch pollen allergy. A double blind studyC Möller, S Dreborg, A Lanner, et al.
Allergy|October 1, 1983
Venom immunotherapy in hymenoptera sting allergy. Comparison of rush and conventional hyposensitization and observations during long-term treatmentU Thurnheer, U Müller, R Stoller, et al.
International Archives of Allergy and Applied Immunology|January 1, 1982
Clinical studies of a purified timothy pollen extract: desensitization therapy with a purified timothy pollen preparation compared to a crude timothy pollen extract. II. Results of the tests in vitro and their relation to symptoms and tests in vivoS L Nordvall, T Berg, S G Johansson, et al.
Acta Paediatrica (Oslo, Norway : 1992)|September 1, 1993
Prevalence of coeliac disease in diabetic children and adolescents in SwedenN Sigurs, C Johansson, P O Elfstrand, et al.
The Journal of Allergy and Clinical Immunology|March 1, 1989
Specific IgE, IgG, and IgA antibody response to oral immunotherapy in birch pollinosisE Taudorf, L Laursen, A Lanner, et al.
International Archives of Allergy and Applied Immunology|January 1, 1985
A double blind study on immunotherapy with chemically modified honey bee venom: monomethoxy polyethylene glycol-coupled versus crude honey bee venomU Müller, A Lanner, P Schmid, et al.
Allergy|July 1, 1985
Reproducibility of histamine skin prick test. Inter- and intravariation using histamine dihydrochloride 1, 5, and 10 mg/mlE Taudorf, H J Malling, L C Laursen, et al.
Scandinavian Journal of Gastroenterology|January 1, 1975
Effect of treatment with a bile-sequestering agent (Secholex) on intestinal absorption, duodenal bile acids, and plasma lipidsS Ritland, O Fausa, E Gjone, et al.
Allergy|February 1, 1986
A preliminary study of immunotherapy with a monomethoxy polyethylene glycol modified honey bee venom preparationS Ohman, J Björkander, S Dreborg, et al.
The Journal of Allergy and Clinical Immunology|September 1, 1987
A double-blind study comparing monomethoxy polyethylene glycol-modified honeybee venom and unmodified honeybee venom for immunotherapy. I. Clinical resultsU Müller, A R Rabson, M Bischof, et al.
Pageof 3